NOS2 and asthma: Instead, multiple alternative pathways, such as peroxynitrite formation, S-nitrosothiol signaling, PGE2 regulation, and superoxide-driven oxidative stress, appear to contribute, resulting in selective iNOS inhibition insufficient to yield therapeutic benefits in asthma.